Cargando…
Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men in Western countries, and there is still an urgent need for a better understanding of PCa progression to inspire new treatment strategies. Skp2 is a substrate-recruiting component of the E3 ubiquitin ligase complex, wh...
Autores principales: | Mickova, Alena, Kharaishvili, Gvantsa, Kurfurstova, Daniela, Gachechiladze, Mariam, Kral, Milan, Vacek, Ondrej, Pokryvkova, Barbora, Mistrik, Martin, Soucek, Karel, Bouchal, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000894/ https://www.ncbi.nlm.nih.gov/pubmed/33799604 http://dx.doi.org/10.3390/ijms22062844 |
Ejemplares similares
-
High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells
por: Šimečková, Šárka, et al.
Publicado: (2019) -
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
por: Kharaishvili, Gvantsa, et al.
Publicado: (2014) -
The Effect of Neddylation Blockade on Slug-Dependent Cancer Cell Migration Is Regulated by p53 Mutation Status
por: Kim, Yelee, et al.
Publicado: (2021) -
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2022) -
The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells
por: Pernicová, Zuzana, et al.
Publicado: (2014)